Your browser is no longer supported. Please, upgrade your browser.
VCYT Veracyte, Inc. daily Stock Chart
VCYT [NASD]
Veracyte, Inc.
Index- P/E- EPS (ttm)-0.19 Insider Own0.80% Shs Outstand49.05M Perf Week-2.30%
Market Cap1.40B Forward P/E- EPS next Y-0.21 Insider Trans-46.88% Shs Float48.16M Perf Month18.15%
Income-8.20M PEG- EPS next Q-0.08 Inst Own96.58% Short Float5.74% Perf Quarter11.41%
Sales116.40M P/S12.01 EPS this Y32.00% Inst Trans9.06% Short Ratio4.50 Perf Half Y-0.18%
Book/sh4.75 P/B6.00 EPS next Y-10.50% ROA-4.40% Target Price34.00 Perf Year117.30%
Cash/sh3.99 P/C7.15 EPS next 5Y- ROE-5.30% 52W Range10.72 - 31.18 Perf YTD126.63%
Dividend- P/FCF- EPS past 5Y12.70% ROI-21.20% 52W High-8.56% Beta1.23
Dividend %- Quick Ratio13.20 Sales past 5Y33.30% Gross Margin69.80% 52W Low165.84% ATR1.08
Employees270 Current Ratio13.60 Sales Q/Q31.90% Oper. Margin-8.60% RSI (14)57.22 Volatility3.25% 4.20%
OptionableYes Debt/Eq0.00 EPS Q/Q87.00% Profit Margin-7.10% Rel Volume0.39 Prev Close28.63
ShortableYes LT Debt/Eq0.00 EarningsJan 21 AMC Payout- Avg Volume614.24K Price28.51
Recom1.30 SMA203.70% SMA5012.85% SMA20012.95% Volume238,708 Change-0.42%
Jul-31-19Initiated Lake Street Buy $35
Jul-02-19Initiated Needham Buy $33
Nov-29-18Downgrade Janney Buy → Neutral
Oct-31-18Upgrade Janney Neutral → Buy
Nov-07-17Downgrade Piper Jaffray Overweight → Neutral
Nov-07-17Downgrade Janney Buy → Neutral
Aug-31-17Resumed BTIG Research Buy $13
Nov-14-16Resumed Leerink Partners Outperform $12
Dec-18-15Initiated Cantor Fitzgerald Buy $13
Jun-11-15Reiterated Leerink Partners Outperform $11 → $13
Nov-26-13Initiated William Blair Outperform
Dec-13-19 09:06AM  Hedge Funds Might Be Selling Veracyte Inc (VCYT), But They Are Still Bullish Insider Monkey
Dec-04-19 11:56AM  Did Business Growth Power Veracyte's (NASDAQ:VCYT) Share Price Gain of 255%? Simply Wall St. +7.94%
07:06AM  The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug Benzinga
Dec-03-19 06:05PM  Peninsula diagnostics company's overseas plans could more than triple revenue American City Business Journals
05:09PM  $50M deal could expand NanoString Technologies diagnostic test into more markets American City Business Journals
05:00PM  Veracyte Acquires Exclusive License to NanoString Diagnostics Platform, Positioning Veracyte To Expand Its Genomic Testing Business Globally Business Wire
Nov-02-19 09:30AM  Veracyte Announces New Data That Advance Understanding of Genomic Alterations Targeted by Precision Medicine Therapies for Thyroid Cancer Business Wire
Oct-31-19 04:30AM  8 Undervalued Biotech Stocks to Watch Now Investopedia
Oct-30-19 08:15AM  Veracyte Announces New Data Characterizing Genomic Alterations in Thyroid Cancer To Be Presented at 89th Annual Meeting of the American Thyroid Association Business Wire
Oct-27-19 02:00PM  Hedge Funds Have Never Been This Bullish On Veracyte Inc (VCYT) Insider Monkey
Oct-24-19 06:42AM  Edited Transcript of VCYT earnings conference call or presentation 22-Oct-19 9:00pm GMT Thomson Reuters StreetEvents -5.97%
Oct-22-19 04:15PM  Veracyte Announces Third Quarter 2019 Financial Results and Business Progress Business Wire
07:00AM  Veracyte Announces New Clinical Data Showing First-Ever Noninvasive Nasal Swab Test Can Enable Early Lung Cancer Detection and Diagnosis Business Wire
Oct-21-19 04:15PM  Veracyte Announces Clinical Data Demonstrating Clinical Validity and Utility of Percepta Classifier in Lung Cancer Diagnosis When Bronchoscopy Results Are Inconclusive Business Wire +6.16%
09:57AM  Veracyte Announces New Data Demonstrating That Envisia Genomic Classifier Improves IPF Diagnosis Business Wire
Oct-09-19 03:14PM  Are Veracyte, Inc. (NASDAQ:VCYT) Investors Paying Above The Intrinsic Value? Simply Wall St. +5.54%
Oct-08-19 04:30PM  Veracyte to Release Third Quarter 2019 Financial Results and Business Progress on October 22, 2019 Business Wire
Oct-07-19 08:00AM  Veracyte to Announce New Clinical Data for First Noninvasive Nasal Swab Test to Target Early Lung Cancer Detection at CHEST Annual Meeting 2019 Business Wire
Sep-11-19 11:04AM  Veracyte Announces Publication of Clinical and Analytical Validation Data for Afirma Xpression Atlas Business Wire
Sep-10-19 08:22AM  Loss-Making Veracyte, Inc. (NASDAQ:VCYT) Expected To Breakeven Simply Wall St.
Aug-28-19 04:15PM  Veracyte to Present at Upcoming Investor Conferences Business Wire
Aug-13-19 12:45PM  Is Veracyte (NASDAQ:VCYT) A Risky Investment? Simply Wall St. +6.69%
Aug-02-19 06:51PM  Edited Transcript of VCYT earnings conference call or presentation 30-Jul-19 9:00pm GMT Thomson Reuters StreetEvents -6.81%
Jul-31-19 01:24AM  Veracyte (VCYT) Q2 2019 Earnings Call Transcript Motley Fool
Jul-30-19 07:45PM  Veracyte (VCYT) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:15PM  Veracyte Announces Second Quarter 2019 Financial Results Business Wire
Jul-23-19 10:32AM  Will Veracyte (VCYT) Report Negative Earnings Next Week? What You Should Know Zacks -7.47%
Jul-17-19 07:42AM  Is Veracyte, Inc.'s (NASDAQ:VCYT) CEO Pay Justified? Simply Wall St.
Jul-01-19 08:00AM  Veracyte Names Keith Kennedy Chief Operating Officer and Chief Financial Officer Business Wire
Jun-27-19 04:15PM  Veracyte to Release Second Quarter 2019 Financial Results on July 30, 2019 Business Wire
Jun-26-19 04:15PM  Veracyte Announces Next-Generation Percepta Genomic Sequencing Classifier Now Available to Physicians for Improved Lung Cancer Diagnosis Business Wire
Jun-24-19 08:30AM  Veracyte Named a San Francisco Bay Area Top Workplace For Sixth Consecutive Year Business Wire
Jun-21-19 09:35AM  Veracyte (VCYT) Hits Fresh High: Is There Still Room to Run? Zacks
Jun-20-19 03:29PM  Hedge Funds Have Never Been This Bullish On Veracyte Inc (VCYT) Insider Monkey
Jun-17-19 08:30AM  Veracyte Announces New Article Published in Cancer Cytopathology Detailing Clinical Utility of Its RNA Sequencing-Based Testing for Thyroid Cancer Diagnosis and Treatment Business Wire
Jun-14-19 02:59PM  7 Top-Rated Biotech Stocks to Invest In Today InvestorPlace
09:49AM  GE wants to unload the portfolio of its Menlo Park venture arm American City Business Journals
Jun-10-19 04:15PM  Veracyte Announces New Publication of Data Demonstrating Real-World Performance of the Afirma GSC in Thyroid Cancer Diagnosis Business Wire
Jun-07-19 09:26AM  Riskalyze hires Bay Area tech executive as CFO American City Business Journals
09:18AM  New Strong Buy Stocks for June 7th Zacks
Jun-01-19 02:15PM  Veracyte Announces New Data Showing Potential of Afirma Genomic Test to Guide Targeted Treatment for Medullary Thyroid Cancer Concurrent with Diagnosis Business Wire
May-30-19 12:49PM  Before You Buy Veracyte, Inc. (NASDAQ:VCYT), Consider Its Volatility Simply Wall St.
May-29-19 04:20PM  Veracyte Announces Participation in Two Upcoming Investor Conferences Business Wire
May-23-19 08:00AM  Veracyte Announces New Data Demonstrating Afirma Xpression Atlass Potential to Inform Treatment Selection for Patients with Medullary Thyroid Cancer to Be Presented at 2019 ASCO Annual Meeting Business Wire
May-20-19 08:00AM  Veracyte Unveils Next-Generation Percepta Genomic Sequencing Classifier for Improved Lung Cancer Diagnosis Business Wire
May-14-19 08:30AM  Veracyte Names Sangeeta Bhorade, M.D., Medical Director of Pulmonology Business Wire +5.27%
May-11-19 12:46PM  Hedge Funds Have Never Been This Bullish On Veracyte Inc (VCYT) Insider Monkey
May-09-19 04:20PM  Veracyte to Present at the UBS Global Healthcare Conference Business Wire
07:46AM  These 3 revolutionary genomics companies are changing lives for patients and investors MarketWatch
May-07-19 04:15PM  Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire -6.67%
May-04-19 03:05AM  Edited Transcript of VCYT earnings conference call or presentation 30-Apr-19 9:00pm GMT Thomson Reuters StreetEvents
May-02-19 07:57PM  Veracyte Announces Pricing of Public Offering of 5,500,000 Shares of Common Stock Business Wire
May-01-19 04:33PM  Veracyte Announces Proposed Public Offering of Common Stock Business Wire +10.06%
07:39AM  The Daily Biotech Pulse: Nabriva Stumbles At FDA Hurdle, Gilead CFO To Retire, Eisai Ends Collaboration With Purdue Benzinga
Apr-30-19 10:44PM  Veracyte (VCYT) Q1 2019 Earnings Call Transcript Motley Fool
06:57PM  Veracyte: 1Q Earnings Snapshot Associated Press
04:15PM  Veracyte Announces First Quarter 2019 Financial Results Business Wire
03:00PM  Veracyte, Inc. to Host Earnings Call ACCESSWIRE
Apr-23-19 10:32AM  Will Veracyte (VCYT) Report Negative Earnings Next Week? What You Should Know Zacks
08:08AM  The Daily Biotech Pulse: FDA Accepts Alder's Migraine Drug Application, Gritstone Offering, Lilly's Chinese Sale Benzinga
Apr-22-19 04:15PM  Veracyte Receives Regulatory Authorization to Offer Envisia Genomic Classifier for Patients in New York State Business Wire
08:30AM  Veracyte Names Alfred Bowie, Jr., Ph.D. as Vice President, Corporate and Business Development Business Wire
Apr-19-19 01:34PM  Can You Imagine How Chuffed Veracyte's (NASDAQ:VCYT) Shareholders Feel About Its 297% Share Price Gain? Simply Wall St.
Apr-09-19 03:33PM  These Cannabis and China ETFs are Leading the 2019 Rally Investopedia
Apr-08-19 07:30AM  Veracyte Announces Publication Highlighting Afirma GSCs Ability to Rule Out Cancer in Challenging Thyroid Nodule Subtype Business Wire
Apr-03-19 08:30AM  Veracyte to Release First Quarter 2019 Financial Results on April 30, 2019 Business Wire
Apr-01-19 06:46PM  Veracyte Announces Data Published in The Lancet Respiratory Medicine Demonstrate that the Envisia Genomic Classifier Improves Diagnosis of IPF Business Wire
Mar-28-19 04:15PM  Veracyte Announces Participation in the 18th Annual Needham Healthcare Conference Business Wire +5.88%
09:49AM  3 Small Biotech Stocks Hitting New Highs Investopedia
Mar-27-19 07:00AM  Research Report Identifies Alamos Gold, Thermo Fisher Scientific, Veracyte, Air Lease, Carlisle Companies, and Medidata Solutions with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire -5.89%
Mar-25-19 04:15PM  Veracyte Announces New Afirma Xpression Atlas Data that Advance Genomic Understanding of Medullary Thyroid Cancer Business Wire +5.31%
Mar-22-19 09:36AM  Will Veracyte Continue to Surge Higher? Zacks
Mar-19-19 07:30AM  Veracyte Announces Sponsorship of the Climb to Fight Cancers Team Kilimanjaro Expedition Business Wire
Mar-18-19 07:30AM  Veracyte Announces New Afirma Xpression Atlas Data on Medullary Thyroid Cancer to Be Presented at ENDO 2019 Business Wire
Mar-14-19 01:10PM  Veracyte, Inc.s (NASDAQ:VCYT) Shift From Loss To Profit Simply Wall St.
11:15AM  Veracyte (VCYT) Reports Q4 Loss, Tops Revenue Estimates Zacks
Mar-05-19 10:53AM  Zacks.com featured highlights include: Radiant, Great Lakes, Clarus, Veracyte and First BanCorp Zacks
Mar-04-19 08:30AM  Veracyte Receives Final Medicare Coverage Policy for Envisia Genomic Classifier Business Wire
07:22AM  5 Stocks With Recent Price Strength to Maximize Your Gains Zacks
Mar-01-19 06:20AM  Edited Transcript of VCYT earnings conference call or presentation 25-Feb-19 10:00pm GMT Thomson Reuters StreetEvents
Feb-26-19 01:52PM  Veracyte Inc (VCYT) Q4 2018 Earnings Conference Call Transcript Motley Fool +9.04%
Feb-25-19 04:15PM  Veracyte Announces Fourth Quarter and Full-Year 2018 Financial Results and Provides 2019 Financial Outlook Business Wire
03:00PM  Veracyte Inc to Host Earnings Call ACCESSWIRE
10:52AM  Veracyte Q4 Earnings Preview Benzinga
Feb-20-19 04:20PM  Veracyte Announces Participation in Upcoming Investor Conferences Business Wire
Feb-18-19 10:30AM  Will Veracyte (VCYT) Report Negative Earnings Next Week? What You Should Know Zacks
Feb-14-19 05:54PM  Veracyte CEO navigated early troubles, now has her company on path to growth American City Business Journals
Feb-06-19 11:53AM  Our Take On Veracyte, Inc.s (NASDAQ:VCYT) CEO Salary Simply Wall St.
Feb-01-19 07:50AM  Research Report Identifies Whirlpool, Adtalem Global Education, Reinsurance Group of America, W.R. Berkley, Veracyte, and 22nd Century Group with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-28-19 04:20PM  Veracyte to Release Fourth Quarter and Full-Year 2018 Financial Results February 25, 2019 Business Wire
Jan-09-19 04:30PM  Veracyte to Present at the 21st Annual Needham Growth Conference Business Wire
Jan-03-19 09:54AM  Can the nose point the way to early lung cancer detection? This Peninsula company's Big Pharma deal aims to find out American City Business Journals +9.08%
07:00AM  Veracyte Announces Strategic Collaboration with Johnson & Johnson Innovation in Battle Against Lung Cancer Business Wire
Jan-02-19 05:54PM  Veracyte to Present at the 37th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-05-18 07:30AM  Veracyte Announces Expansion of Envisia Genomic Classifier Early Access Program Business Wire
Nov-23-18 08:55AM  Investor Expectations to Drive Momentum within Cel-Sci, DGSE Companies, Veracyte, China Pharma, Barnwell Industries, and Silvercrest Asset Management Group Discovering Underlying Factors of Influence GlobeNewswire
Nov-09-18 08:30AM  Veracyte to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum Business Wire
Nov-08-18 04:24PM  Veracyte Announces Publication of Data Demonstrating Real World Performance of Afirma GSC in Thyroid Cancer Diagnosis Business Wire +5.92%
Nov-01-18 11:07AM  Edited Transcript of VCYT earnings conference call or presentation 29-Oct-18 8:30pm GMT Thomson Reuters StreetEvents -12.39%
Oct-31-18 12:00PM  3 Healthcare Stocks Leading New Industry Trends ACCESSWIRE +28.46%
Veracyte, Inc. operates as a genomic diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas solutions for a complex landscape in thyroid nodule diagnosis to physicians; Percepta Bronchial Genomic Classifier solution for use in lung cancer diagnosis; and Envisia Genomic Classifier solution for the diagnosis of idiopathic pulmonary fibrosis. It sells its products through product specialists, account managers, and medical science specialists. Veracyte, Inc. has a strategic collaboration with Johnson & Johnson, LLC and Johnson & Johnson's Lung Cancer Initiative to advance diagnostics of a nasal swab test for early lung cancer detection; a research collaboration with Loxo Oncology for the development of therapies for patients with genetically defined cancers; and an agreement with Johnson & Johnson Services, Inc. for the development and commercialization of novel diagnostic tests to detect lung cancer. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anderson Bonnie HChairman and CEODec 10Option Exercise3.4335,000120,200122,738Dec 11 04:46 PM
Anderson Bonnie HChairman and CEODec 10Sale28.9620,000579,248102,738Dec 11 04:46 PM
Kennedy KeithCOO / CFODec 06Option Exercise7.4713,851103,467123,554Dec 09 04:12 PM
Hanna John Walter JRChief Commercial OfficerDec 06Option Exercise9.059,83889,03475,113Dec 09 04:17 PM
JONES EVAN/ FADirectorDec 06Sale30.0380024,022173,702Dec 09 04:19 PM
Hanna John Walter JRChief Commercial OfficerDec 06Sale30.099,838295,99565,275Dec 09 04:17 PM
Kennedy KeithCOO / CFODec 06Sale30.0413,851416,146109,703Dec 09 04:12 PM
Kennedy KeithCOO / CFODec 05Option Exercise6.9019,300133,208129,003Dec 09 04:12 PM
Kennedy Giulia CChief Scientific & Med OfficerDec 05Option Exercise14.3432,803470,39579,665Dec 09 04:15 PM
Hanna John Walter JRChief Commercial OfficerDec 05Option Exercise9.058,10073,30573,375Dec 09 04:17 PM
JONES EVAN/ FADirectorDec 05Sale30.005,151154,535174,502Dec 09 04:19 PM
Hanna John Walter JRChief Commercial OfficerDec 05Sale30.018,100243,04765,275Dec 09 04:17 PM
Kennedy Giulia CChief Scientific & Med OfficerDec 05Sale29.3932,803964,14246,862Dec 09 04:15 PM
Kennedy KeithCOO / CFODec 05Sale30.0019,300579,069109,703Dec 09 04:12 PM
Kennedy Giulia CChief Scientific & Med OfficerDec 03Option Exercise7.1215,032107,10362,189Dec 04 04:22 PM
Kennedy Giulia CChief Scientific & Med OfficerDec 03Sale26.4715,327405,66346,862Dec 04 04:22 PM
Kennedy Giulia CChief Scientific & Med OfficerNov 27Option Exercise14.343,69753,01551,146Dec 02 04:13 PM
Kennedy Giulia CChief Scientific & Med OfficerNov 27Sale29.363,697108,53447,449Dec 02 04:13 PM
Hanna John Walter JRChief Commercial OfficerNov 26Option Exercise8.9915,497139,34680,989Nov 27 04:30 PM
Hanna John Walter JRChief Commercial OfficerNov 26Sale28.5515,497442,48065,492Nov 27 04:30 PM
Kennedy KeithCOO / CFONov 25Option Exercise5.9818,757112,167128,800Nov 27 04:28 PM
Hanna John Walter JRChief Commercial OfficerNov 25Option Exercise8.982,44121,91567,933Nov 27 04:30 PM
Hanna John Walter JRChief Commercial OfficerNov 25Sale28.522,44169,61065,492Nov 27 04:30 PM
Kennedy KeithCOO / CFONov 25Sale28.0118,757525,475110,043Nov 27 04:28 PM
Hanna John Walter JRChief Commercial OfficerNov 18Option Exercise6.4519,571126,23385,063Nov 19 05:38 PM
Hanna John Walter JRChief Commercial OfficerNov 18Sale25.1819,571492,78865,492Nov 19 05:38 PM
Anderson Bonnie HChairman and CEONov 15Option Exercise4.0020,00080,000123,726Nov 18 04:19 PM
Anderson Bonnie HChairman and CEONov 15Sale25.0620,000501,124103,726Nov 18 04:19 PM
Kennedy KeithCOO / CFOOct 22Option Exercise5.981,2437,433111,286Oct 24 06:39 PM
Hanna John Walter JRChief Commercial OfficerOct 22Option Exercise6.4516,091103,78781,583Oct 24 06:42 PM
Hanna John Walter JRChief Commercial OfficerOct 22Sale27.5116,091442,72965,492Oct 24 06:42 PM
Kennedy KeithCOO / CFOOct 22Sale28.001,24334,804110,043Oct 24 06:39 PM
Anderson Bonnie HChairman and CEOOct 10Option Exercise3.097,30022,546111,726Oct 11 04:25 PM
Anderson Bonnie HChairman and CEOOct 10Sale24.508,000196,005103,726Oct 11 04:25 PM
Kennedy KeithCOO / CFOSep 18Option Exercise7.4722,365167,067110,043Sep 20 04:06 PM
Hanna John Walter JRChief Commercial OfficerSep 16Option Exercise5.9818,593111,18684,085Sep 17 04:50 PM
Hanna John Walter JRChief Commercial OfficerSep 16Sale25.6618,593477,08965,492Sep 17 04:50 PM
Anderson Bonnie HChairman and CEOSep 10Sale24.518,000196,114104,426Sep 12 05:45 PM
Kennedy Giulia CChief Scientific & Med OfficerSep 04Sale25.202967,45847,449Sep 05 05:23 PM
Kennedy Giulia CChief Scientific & Med OfficerSep 03Option Exercise7.1315,031107,10063,068Sep 05 05:23 PM
Kennedy Giulia CChief Scientific & Med OfficerSep 03Sale25.3215,031380,65648,037Sep 05 05:23 PM
JONES EVAN/ FADirectorAug 28Sale26.106,600172,290179,653Aug 29 04:32 PM
JONES EVAN/ FADirectorAug 27Sale26.113,40088,760186,253Aug 29 04:32 PM
Kennedy Giulia CChief Scientific & Med OfficerAug 13Option Exercise10.454,64048,48852,677Aug 14 04:15 PM
Kennedy Giulia CChief Scientific & Med OfficerAug 13Sale25.454,640118,08848,037Aug 14 04:15 PM
Kennedy Giulia CChief Scientific & Med OfficerAug 12Option Exercise8.3027,962232,09576,294Aug 14 04:15 PM
Anderson Bonnie HChairman and CEOAug 12Option Exercise2.681,4593,910121,414Aug 13 05:08 PM
Anderson Bonnie HChairman and CEOAug 12Sale25.288,000202,237113,414Aug 13 05:08 PM
Kennedy Giulia CChief Scientific & Med OfficerAug 12Sale25.3828,257717,09548,037Aug 14 04:15 PM
JONES EVAN/ FADirectorAug 09Sale26.3815,000395,681189,653Aug 12 04:24 PM
Cohen Fred EDirectorAug 02Option Exercise9.2140,000368,20040,000Aug 05 04:17 PM
Anderson Bonnie HChairman and CEOJul 10Option Exercise2.688,00021,440127,955Jul 11 05:02 PM
Anderson Bonnie HChairman and CEOJul 10Sale28.798,000230,314119,955Jul 11 05:02 PM
Anderson Bonnie HChairman and CEOJun 10Option Exercise2.688,00021,440127,955Jun 11 04:36 PM
Anderson Bonnie HChairman and CEOJun 10Sale26.338,000210,635119,955Jun 11 04:36 PM
Anderson Bonnie HChairman and CEOJun 04Option Exercise2.3625,65160,536119,955Jun 05 04:21 PM
Anderson Bonnie HChairman and CEOMay 10Option Exercise2.688,00021,440103,292May 13 04:28 PM
Anderson Bonnie HChairman and CEOMay 10Sale22.998,000183,94895,292May 13 04:28 PM
Hall Christopher MPresident and COOMay 06Option Exercise7.31115,000840,775143,714May 08 04:30 PM
Hall Christopher MPresident and COOMay 06Sale25.26115,0002,904,71528,714May 08 04:30 PM
Hall Christopher MPresident and COOApr 11Option Exercise4.1880,000334,067108,714Apr 12 04:51 PM
Hall Christopher MPresident and COOApr 11Sale25.1280,0002,009,68428,714Apr 12 04:51 PM
Anderson Bonnie HChairman and CEOApr 10Option Exercise2.688,00021,440103,292Apr 11 05:17 PM
Anderson Bonnie HChairman and CEOApr 10Sale25.398,000203,08495,292Apr 11 05:17 PM
Anderson Bonnie HChairman and CEOMar 11Option Exercise2.688,00021,440110,592Mar 13 04:58 PM
Anderson Bonnie HChairman and CEOMar 11Sale19.978,000159,746102,592Mar 13 04:58 PM
Kennedy Giulia CChief Scientific & Med OfficerMar 04Option Exercise5.9817,625105,39866,249Mar 05 04:48 PM
TREU JESSE IDirectorMar 04Sale20.21427,1518,632,7220Mar 04 06:03 PM
Kennedy Giulia CChief Scientific & Med OfficerMar 04Sale20.2417,625356,70948,624Mar 05 04:48 PM
TREU JESSE IDirectorMar 01Sale20.45275,0005,623,75012,193Mar 04 06:03 PM
Kennedy Giulia CChief Scientific & Med OfficerFeb 28Option Exercise7.9937,375298,75586,775Mar 04 07:05 PM
TREU JESSE IDirectorFeb 28Sale20.50350,0007,176,40014,216Mar 04 06:03 PM
JONES EVAN/ FADirectorFeb 28Sale20.3775,0001,527,803204,653Mar 04 07:11 PM
Kennedy Giulia CChief Scientific & Med OfficerFeb 28Sale20.4537,375764,20449,400Mar 04 07:05 PM
Anderson Bonnie HChairman and CEOFeb 11Option Exercise2.688,00021,44084,541Feb 12 05:29 PM
Anderson Bonnie HChairman and CEOFeb 11Sale18.178,000145,36476,541Feb 12 05:29 PM
Anderson Bonnie HChairman and CEOJan 10Option Exercise2.688,00021,44084,541Jan 11 05:24 PM
Anderson Bonnie HChairman and CEOJan 10Sale15.668,000125,24876,541Jan 11 05:24 PM
Anderson Bonnie HChairman and CEOJan 09Option Exercise2.6817,50046,90094,041Jan 11 05:24 PM
Anderson Bonnie HChairman and CEOJan 09Sale15.1217,500264,64976,541Jan 11 05:24 PM